Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

New York - Presbyterian Hospital-Weill Cornell Medical Center, New York

Fondazionerca sul Cancro ONLUS - Istituto di Candiolo IRCCS, Candiolo

Memorial Sloan Kettering Cancer Center, New York

New York Oncology Hematology, P.C. (USO - US Oncology), Albany

Roswell Park Cancer Institute, Buffalo

Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela

Penn State Hershey Medical Center, Hershey

Lehigh Valley Health Network, Allentown

Medstar Georgetown University Medical Center, Washington D.C.

IRCCS Ospedale San Raffaele - Medical Oncology Dept, Milan

Fondazione IRCCS Istituto Nazionale Tumori, Milan

University of Maryland, Marlene and Stewart Greenebaum Cancer Center, Baltimore

University of Virginia, Emily Couric Clinical Center, Charlottesville

Universitatsklinikum Munster / Urologie und Kinderurologie, Münster

Duke University, Duke Cancer Institute, Durham

Hospital General Universitario Gregorio Maranon, Madrid

Clinica Universitaria de Navarra Madrid, Madrid

MD Anderson Cancer Center, Madrid

Hospital Universitario 12 de Octubre, Madrid

Atlantic Urology Clinics, Myrtle Beach

Universidad de Navarra - Clinica Universitaria de Navarra, Pamplona

Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse

Miami Cancer Institute, Baptist Health South Florida, Miami

Urology Associates, Nashville

University Oncology & Hematology, Chattanooga

Norton Cancer Center, Louisville

Centre de Lutte Contre le Cancer - Institut de Cancerologie de l'Ouest - Rene Gauducheau, Saint-Herblain

Indiana University - Melvin and Bren Simon Cancer Center (IUSCC), Indianapolis

University of Michigan, Ann Arbor

The University of Iowa and Holden Comprehensive Cancer Center, Iowa City

Froedtert & Medical College of Wisconsin, Milwaukee

Minnesota Oncology Hematology P.A. (USO - US Oncology), Minneapolis

Northwestern University, Chicago, Chicago

Centre de Lutte Contre le Cancer (CLCC) - Universite de Lyon - Centre Leon-Berard, Lyon

Ochsner Cancer Institute, New Orleans

Studienpraxis Urologie, Nürtingen

Stephenson Cancer Center, Oklahoma City

Hopital Saint-Louis, Paris

Texas Oncology PA (USO - US Oncology), Dallas

University of Texas, UT Health Science Center, Houston

Azienda Ospedaliera Universitaria Federico II Oncologia Medica, Naples

University of Utah, Huntsman Cancer Institute, Salt Lake City

Pinnacle Oncology, Honor Health, Scottsdale

University of New Mexico UNM Cancer Research and Treatment Center, Albuquerque

Comprehensive Cancer Centers of Nevada (CCCN), Las Vegas

University of California, Los Angeles (UCLA), Los Angeles

Saint John's Health Center - John Wayne Cancer Institute (JWCI), Santa Monica

Urologische und Kinderurologische Universitätsklinik im Malteser, Erlangen

University of California San Diego (UCSD), Moores Cancer Center, La Jolla

Universityof California, Irvine, Orange

Stanford University School of Medicine, Stanford

Institut Gustave Roussy, Villejuif

Northwest Cancer Specialists P.C. (USO - US Oncology), Portland

Providence Portland Medical Center, Portland

Oregon Health and Science University, Portland

University of Washington / Seattle Cancer Care Alliance, Seattle

Hartford Health Care Cancer Institute, Hartford

Eastern Connecticut Hematology & Oncology Associates (ECHO), Norwich

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

Hospital del Mar, Barcelona

Hospital Santa Creu i Sant Pau, Barcelona

Hospital Universitari Vall d'Hebron de Barcelona, Barcelona

Sarah Cannon Research Institute - United Kingdom - London Office, London

Guy's & St. Thomas' Hospital (London Oncology Clinic), London